ESMO (European Society for Medical Oncology) Congress

NANETS (North American Neuroendocrine Tumor Society) Symposium

34th Annual Congress of the European Association of Nuclear Medicine (EANM)

7èmes Journées Françaises de Médecine Nucléaire (JFMN)

American Society of Clinical Oncology (ASCO) Annual Meeting

Journées d’Onco-Urologie Médicale (JOUM)

Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

Novartis expands targeted radioligand therapy pipeline with in-license for compounds targeting Fibroblast Activation Protein (FAP)

23rd European Congress of Endocrinology (ECE)

Novartis announces positive result of phase III study with radioligand therapy 177Lu-PSMA-617 in patients with advanced prostate cancer